Saxagliptin for type 2 diabetes
Antonio R Chacra, MDDiabetes Center, Federal University of São Paulo, BrazilAbstract: Saxagliptin (Onglyza™) is a potent, selective, once-daily dipeptidyl peptidase-4 (DPP-4) inhibitor indicated for improving glycemic control in patients with type 2 diabetes (T2D). By blocking DPP-4, sa...
Gorde:
| Egile nagusia: | |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Dove Medical Press
2010-09-01
|
| Saila: | Diabetes, Metabolic Syndrome and Obesity |
| Gaiak: | |
| Sarrera elektronikoa: | https://www.dovepress.com/saxagliptin-for-type-2-diabetes-peer-reviewed-article-DMSO |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|